Cargando…

RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy

RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not only because of the complexity of the tumor microenv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nuannuan, Sun, Yiying, Fu, Yuanlei, Sun, Kaoxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740118/
https://www.ncbi.nlm.nih.gov/pubmed/35002692
http://dx.doi.org/10.3389/fphar.2021.734443
_version_ 1784629244820717568
author Li, Nuannuan
Sun, Yiying
Fu, Yuanlei
Sun, Kaoxiang
author_facet Li, Nuannuan
Sun, Yiying
Fu, Yuanlei
Sun, Kaoxiang
author_sort Li, Nuannuan
collection PubMed
description RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not only because of the complexity of the tumor microenvironment, but also due to the intrinsic obstacles of RNAs. Until now, all kinds of strategies have been developed to improve the performance of RNAs for cancer therapy, especially the nanoparticle-based ones using biogenic materials. They are much more compatible with less toxicity compared to the ones using synthetic polymers, and the most widely studied biogenic materials are oligonucleotides, exosomes, and cell membranes. Particular characteristics make them show different capacities in internalization and endosomal escape as well as specific targeting. In this paper, we systematically summarize the RNA-based nano-delivery systems using biogenic materials for cancer therapy, and we believe this review will provide a valuable reference for researchers involved in the field of biogenic delivery and RNA-based therapies for cancer treatment.
format Online
Article
Text
id pubmed-8740118
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-87401182022-01-08 RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy Li, Nuannuan Sun, Yiying Fu, Yuanlei Sun, Kaoxiang Front Pharmacol Pharmacology RNA-based therapies have been promising method for treating all kinds of diseases, and four siRNA-based drugs and two mRNA-based drugs have been approved and are on the market now. However, none of them is applied for cancer treatment. This is not only because of the complexity of the tumor microenvironment, but also due to the intrinsic obstacles of RNAs. Until now, all kinds of strategies have been developed to improve the performance of RNAs for cancer therapy, especially the nanoparticle-based ones using biogenic materials. They are much more compatible with less toxicity compared to the ones using synthetic polymers, and the most widely studied biogenic materials are oligonucleotides, exosomes, and cell membranes. Particular characteristics make them show different capacities in internalization and endosomal escape as well as specific targeting. In this paper, we systematically summarize the RNA-based nano-delivery systems using biogenic materials for cancer therapy, and we believe this review will provide a valuable reference for researchers involved in the field of biogenic delivery and RNA-based therapies for cancer treatment. Frontiers Media S.A. 2021-12-24 /pmc/articles/PMC8740118/ /pubmed/35002692 http://dx.doi.org/10.3389/fphar.2021.734443 Text en Copyright © 2021 Li, Sun, Fu and Sun. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Li, Nuannuan
Sun, Yiying
Fu, Yuanlei
Sun, Kaoxiang
RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
title RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
title_full RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
title_fullStr RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
title_full_unstemmed RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
title_short RNA Drug Delivery Using Biogenic Nanovehicles for Cancer Therapy
title_sort rna drug delivery using biogenic nanovehicles for cancer therapy
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740118/
https://www.ncbi.nlm.nih.gov/pubmed/35002692
http://dx.doi.org/10.3389/fphar.2021.734443
work_keys_str_mv AT linuannuan rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy
AT sunyiying rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy
AT fuyuanlei rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy
AT sunkaoxiang rnadrugdeliveryusingbiogenicnanovehiclesforcancertherapy